Document Detail


Tumour invasion and metastasis: challenges facing drug discovery.
MedLine Citation:
PMID:  15955738     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Initial attempts at directly targeting metastatic spread using inhibitors of matrix metalloproteases failed to deliver the promise of anti-invasive therapy. A new generation of targeted agents with the potential to act as anti-invasives has recently entered the clinic but there is, as yet, no clear route to demonstrate an effect upon tumour metastasis. Because advances with monoclonal antibodies are likely to increase the number of potential anti-invasive agents, more clinically predictive drug discovery cascades are required to reduce the perceived risks associated with their generation. Once they reach the clinic, new approaches will be essential to help early indicators of clinical response meet ethical standards and avoid unnecessary clinical failures.
Authors:
Paul Elvin; Andrew P Garner
Related Documents :
20458888 - Ingestion-controlling network: what's language got to do with it?
20221898 - In-silico approaches to multi-target drug discovery : computer aided multi-target drug ...
20359578 - Multidimensional atomic force microscopy for drug discovery: a versatile tool for defin...
20687178 - Systems pharmacology.
1543618 - The use of temazepam elixir in surgical dental sedation: a comparison with intravenous ...
9229018 - The activity of triple combinations of antifolate biguanides, with and without folinic ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in pharmacology     Volume:  5     ISSN:  1471-4892     ISO Abbreviation:  Curr Opin Pharmacol     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-07-06     Completed Date:  2006-05-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100966133     Medline TA:  Curr Opin Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  374-81     Citation Subset:  IM    
Affiliation:
AstraZeneca, Cancer and Infection Research Area, Mereside, Alderley Park, Macclesfield, SK10 4TG, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Drug Design*
Humans
Neoplasm Invasiveness / physiopathology,  prevention & control*
Neoplasm Metastasis / physiopathology,  prevention & control*
Neoplasms / drug therapy,  physiopathology
Technology, Pharmaceutical / methods,  trends

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Identification of G-protein-coupled receptors involved in inflammatory disease by genetic associatio...
Next Document:  mTOR--beyond transplantation.